Eclitasertib (DNL-758) is a potent receptor-interacting protein kinase 1 ( RIPK1 ) inhibitor with an IC 50 of 0.0375 µΜ.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > RIP kinase
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。